Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Heart Failure Reviews
Erschienen in: Heart Failure Reviews 2/2017

16.01.2017

Exercise capacity, physical activity, and morbidity

verfasst von: Danielle L. Brunjes, Peter J. Kennel, P. Christian Schulze

Erschienen in: Heart Failure Reviews | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Muscle weakness and atrophy are key characteristics of the aging adult but can also be found in chronically ill patients with heart failure, cancer, renal failure, and chronic infectious diseases all associated with an accelerated level of muscle dysfunction. Reduced physical activity levels and exercise intolerance increase muscle loss and decrease quality of life in both the aging and heart failure populations. The purpose of this review is to provide an overview of the effects of aging and heart failure on skeletal muscle function and how exercise training can improve long-term outcomes associated with skeletal muscle dysfunction.
Literatur
1.
2.
Brassard P, Maltais F, Noel M, Doyon JF, LeBlanc P, Allaire J et al (2006) Skeletal muscle endurance and muscle metabolism in patients with chronic heart failure. The Canadian journal of cardiology 22(5):387–392CrossRefPubMedPubMedCentral
3.
Duscha BD, Schulze PC, Robbins JL, Forman DE (2008) Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training. Heart Fail Rev 13(1):21–37CrossRefPubMed
4.
Montero-Fernandez N, Serra-Rexach JA (2013) Role of exercise on sarcopenia in the elderly. European journal of physical and rehabilitation medicine 49(1):131–143PubMed
5.
Rolland Y, Abellan van Kan G, Gillette-Guyonnet S, Vellas B (2011) Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care. 14(1):15–21CrossRefPubMed
6.
Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M (2012) Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 3:260CrossRefPubMedPubMedCentral
7.
Andersen JL (2003) Muscle fibre type adaptation in the elderly human muscle. Scand J Med Sci Sports 13(1):40–47CrossRefPubMed
8.
Boffoli D, Scacco SC, Vergari R, Solarino G, Santacroce G, Papa S (1994) Decline with age of the respiratory chain activity in human skeletal muscle. Biochim Biophys Acta 1226(1):73–82CrossRefPubMed
9.
Porter C, Hurren NM, Cotter MV, Bhattarai N, Reidy PT, Dillon EL et al (2015) Mitochondrial respiratory capacity and coupling control decline with age in human skeletal muscle. Am J Physiol Endocrinol Metab 309(3):E224–E232CrossRefPubMedPubMedCentral
10.
Rasmussen UF, Krustrup P, Kjaer M, Rasmussen HN (2003) Human skeletal muscle mitochondrial metabolism in youth and senescence: no signs of functional changes in ATP formation and mitochondrial oxidative capacity. Pflugers Arch 446(2):270–278CrossRefPubMed
11.
Johnson ML, Lanza IR, Short DK, Asmann YW, Nair KS (2014) Chronically endurance-trained individuals preserve skeletal muscle mitochondrial gene expression with age but differences within age groups remain. Physiol Rep 2(12). doi:10.​14814/​phy2.​12239
12.
Demontis F, Piccirillo R, Goldberg AL, Perrimon N (2013) The influence of skeletal muscle on systemic aging and lifespan. Aging Cell 12(6):943–949CrossRefPubMed
13.
Ruiz JR, Sui X, Lobelo F, Morrow JR Jr, Jackson AW, Sjostrom M et al (2008) Association between muscular strength and mortality in men: prospective cohort study. BMJ 337:a439CrossRefPubMed
14.
15.
Sharples AP, Hughes DC, Deane CS, Saini A, Selman C, Stewart CE (2015) Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake. Aging Cell 14(4):511–523CrossRefPubMedPubMedCentral
16.
Rasmussen BB, Fujita S, Wolfe RR, Mittendorfer B, Roy M, Rowe VL et al (2006) Insulin resistance of muscle protein metabolism in aging. FASEB J 20(6):768–769PubMedPubMedCentral
17.
18.
Perkisas S, Vandewoude M (2016) Where frailty meets diabetes. Diabetes Metab Res Rev 32(1):261-7
19.
20.
Schaap LA, Pluijm SM, Deeg DJ, Visser M (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119(6):526 e9–526 17CrossRef
21.
Budui SL, Rossi AP, Zamboni M (2015) The pathogenetic bases of sarcopenia. Clin Cases Miner Bone Metab 12(1):22–26PubMedPubMedCentral
22.
23.
Frost RA, Lang CH (2007) Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol (1985) 103(1):378–387CrossRef
24.
Santos-Parker JR, LaRocca TJ, Seals DR (2014) Aerobic exercise and other healthy lifestyle factors that influence vascular aging. Adv Physiol Educ 38(4):296–307CrossRefPubMedPubMedCentral
25.
Barker WH, Mullooly JP, Getchell W (2006) Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation 113(6):799–805CrossRefPubMed
26.
Haykowsky MJ, Brubaker PH, Stewart KP, Morgan TM, Eggebeen J, Kitzman DW (2012) Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol 60(2):120–128CrossRefPubMedPubMedCentral
27.
Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL et al (1992) Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85(4):1364–1373CrossRefPubMed
28.
29.
Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A et al (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92(6):1479–1486CrossRefPubMed
30.
Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW et al (1996) Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28(4):964–971CrossRefPubMed
31.
Clark AL, Poole-Wilson PA, Coats AJ (1996) Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 28(5):1092–1102CrossRefPubMed
32.
Sullivan MJ, Duscha BD, Klitgaard H, Kraus WE, Cobb FR, Saltin B (1997) Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure. Med Sci Sports Exerc 29(7):860–866CrossRefPubMed
33.
Drexler H, Riede U, Munzel T, Konig H, Funke E, Just H (1992) Alterations of skeletal muscle in chronic heart failure. Circulation 85(5):1751–1759CrossRefPubMed
34.
Hambrecht R, Fiehn E, Yu J, Niebauer J, Weigl C, Hilbrich L et al (1997) Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 29(5):1067–1073CrossRefPubMed
35.
Simonini A, Chang K, Yue P, Long CS, Massie BM (1999) Expression of skeletal muscle sarcoplasmic reticulum calcium-ATPase is reduced in rats with postinfarction heart failure. Heart 81(3):303–307CrossRefPubMedPubMedCentral
36.
Spangenburg EE, Lees SJ, Otis JS, Musch TI, Talmadge RJ, Williams JH (2002) Effects of moderate heart failure and functional overload on rat plantaris muscle. J Appl Physiol (1985) 92(1):18–24
37.
Simonini A, Long CS, Dudley GA, Yue P, McElhinny J, Massie BM (1996) Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circ Res 79(1):128–136CrossRefPubMed
38.
Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J et al (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18(1):39–51CrossRefPubMed
39.
Schulze PC, Fang J, Kassik KA, Gannon J, Cupesi M, MacGillivray C et al (2005) Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction. Circ Res 97(5):418–426CrossRefPubMed
40.
Wang EY, Biala AK, Gordon JW, Kirshenbaum LA (2012) Autophagy in the heart: too much of a good thing? J Cardiovasc Pharmacol 60(2):110–117CrossRefPubMed
41.
42.
Carnio S, LoVerso F, Baraibar MA, Longa E, Khan MM, Maffei M et al (2014) Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging. Cell Rep 8(5):1509–1521CrossRefPubMedPubMedCentral
43.
Sacheck JM, Hyatt JP, Raffaello A, Jagoe RT, Roy RR, Edgerton VR et al (2007) Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 21(1):140–155CrossRefPubMed
44.
Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH et al (2006) PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A 103(44):16260–16265CrossRefPubMedPubMedCentral
45.
Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM (2010) Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 56(11):855–863CrossRefPubMed
46.
Bhella PS, Prasad A, Heinicke K, Hastings JL, Arbab-Zadeh A, Adams-Huet B et al (2011) Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail 13(12):1296–1304CrossRefPubMedPubMedCentral
47.
48.
Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD et al (2003) Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 107(8):1210–1225CrossRefPubMed
49.
Argiles JM, Busquets S, Felipe A, Lopez-Soriano FJ (2005) Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol 37(5):1084–1104CrossRefPubMed
50.
Bowen TS, Schuler G, Adams V (2015) Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 6(3):197–207CrossRefPubMedPubMedCentral
51.
52.
Sousa-Victor P, Gutarra S, Garcia-Prat L, Rodriguez-Ubreva J, Ortet L, Ruiz-Bonilla V et al (2014) Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 506(7488):316–321CrossRefPubMed
53.
Templeton DL, Kelly AS, Steinberger J, Dengel DR (2010) Lower relative bone mineral content in obese adolescents: role of non-weight bearing exercise. Pediatr Exerc Sci 22(4):557–568CrossRefPubMed
54.
Society AT (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 152(5 Pt 2):S77–121
55.
Kim S, Yamabe H, Yokoyama M (1999) Hemodynamic characteristics during treadmill and bicycle exercise in chronic heart failure: mechanism for different responses of peak oxygen uptake. Jpn Circ J 63(12):965–970CrossRefPubMed
56.
Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI et al (1993) Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators Jama 270(14):1702–1707PubMed
57.
Chung CJ, Wu C, Jones M, Kato TS, Dam TT, Givens RC et al (2014) Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement. J Card Fail 20(5):310–315CrossRefPubMedPubMedCentral
58.
Forman DE, Daniels KM, Cahalin LP, Zavin A, Allsup K, Cao P, et al (2014) Analysis of skeletal muscle gene expression patterns and the impact of functional capacity in patients with systolic heart failure. Journal of cardiac failure. 20(6):422-30
59.
Zavin A, Daniels K, Arena R, Allsup K, Lazzari A, Joseph J et al (2013) Adiposity facilitates increased strength capacity in heart failure patients with reduced ejection fraction. Int J Cardiol 167(6):2468–2471CrossRefPubMed
60.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39(4):412–423CrossRefPubMedPubMedCentral
61.
McLean RR, Shardell MD, Alley DE, Cawthon PM, Fragala MS, Harris TB et al (2014) Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci 69(5):576–583CrossRefPubMedPubMedCentral
62.
Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ (2014) Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 68(9):1001–1007CrossRefPubMed
63.
Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M et al (2013) Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 42(2):203–209CrossRefPubMed
64.
65.
Farkas J, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M (2013) Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle. 4(3):173–178CrossRefPubMedPubMedCentral
66.
Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM et al (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349(9058):1050–1053CrossRefPubMed
67.
von Haehling S, Lainscak M, Springer J, Anker SD (2009) Cardiac cachexia: a systematic overview. Pharmacol Ther 121(3):227–252CrossRef
68.
von Haehling S, Anker SD (2010) Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle. 1(1):1–5CrossRef
69.
Kalantar-Zadeh K, Rhee C, Sim JJ, Stenvinkel P, Anker SD, Kovesdy CP (2013) Why cachexia kills: examining the causality of poor outcomes in wasting conditions. J Cachexia Sarcopenia Muscle 4(2):89–94CrossRefPubMedPubMedCentral
70.
Alves CR, da Cunha TF, da Paixao NA, Brum PC (2015) Aerobic exercise training as therapy for cardiac and cancer cachexia. Life Sci 125:9–14CrossRefPubMed
71.
von Haehling S, Anker SD (2014) Treatment of cachexia: an overview of recent developments. J Am Med Dir Assoc 15(12):866–872CrossRef
72.
Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43(6):748–759CrossRefPubMedPubMedCentral
73.
Forman DE, Clare R, Kitzman DW, Ellis SJ, Fleg JL, Chiara T et al (2009) Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study. Am Heart J 158(4 Suppl):S6–S15CrossRefPubMedPubMedCentral
74.
O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ et al (2009) Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301(14):1439–1450CrossRefPubMedPubMedCentral
75.
Lavie CJ, Arena R, Swift DL, Johannsen NM, Sui X, Lee DC et al (2015) Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ Res 117(2):207–219CrossRefPubMedPubMedCentral
76.
Lee DC, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN (2014) Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol 64(5):472–481CrossRefPubMedPubMedCentral
77.
Wen CP, Wai JP, Tsai MK, Yang YC, Cheng TY, Lee MC et al (2011) Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 378(9798):1244–1253CrossRefPubMed
78.
Taylor RS, Sagar VA, Davies EJ, Briscoe S, Coats AJ, Dalal H et al (2014) Exercise-based rehabilitation for heart failure. The Cochrane database of systematic reviews 4:CD003331
79.
Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A et al (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376(9744):886–894CrossRefPubMed
80.
Gielen S, Laughlin MH, O'Conner C, Duncker DJ (2015) Exercise training in patients with heart disease: review of beneficial effects and clinical recommendations. Prog Cardiovasc Dis 57(4):347–355CrossRefPubMed
81.
Raymond MJ, Bramley-Tzerefos RE, Jeffs KJ, Winter A, Holland AE (2013) Systematic review of high-intensity progressive resistance strength training of the lower limb compared with other intensities of strength training in older adults. Arch Phys Med Rehabil 94(8):1458–1472CrossRefPubMed
82.
Arena R, Myers J, Forman DE, Lavie CJ, Guazzi M (2013) Should high-intensity-aerobic interval training become the clinical standard in heart failure? Heart Fail Rev 18(1):95–105CrossRefPubMed
83.
Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM et al (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115(24):3086–3094CrossRefPubMed
84.
Hirai DM, Musch TI, Poole DC (2015) Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization. Am J Physiol Heart Circ Physiol 309(9):1419–39
85.
Coats AJ (2011) Clinical utility of exercise training in chronic systolic heart failure. Nat Rev Cardiol 8(7):380–392CrossRefPubMed
86.
Esposito F, Reese V, Shabetai R, Wagner PD, Richardson RS (2011) Isolated quadriceps training increases maximal exercise capacity in chronic heart failure: the role of skeletal muscle convective and diffusive oxygen transport. J Am Coll Cardiol 58(13):1353–1362CrossRefPubMedPubMedCentral
Metadaten
Titel
Exercise capacity, physical activity, and morbidity
verfasst von
Danielle L. Brunjes
Peter J. Kennel
P. Christian Schulze
Publikationsdatum
16.01.2017
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 2/2017
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-016-9592-1

Weitere Artikel der Ausgabe 2/2017

Heart Failure Reviews 2/2017 Zur Ausgabe

OriginalPaper

Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology

OriginalPaper

Heart failure in the elderly: ten peculiar management considerations

OriginalPaper

SPECT and PET in ischemic heart failure

ReviewPaper

Peripheral vascular function, oxygen delivery and utilization: the impact of oxidative stress in aging and heart failure with reduced ejection fraction

ReviewPaper

MicroRNAs, heart failure, and aging: potential interactions with skeletal muscle

ReviewPaper

Heart failure with preserved ejection fraction and skeletal muscle physiology

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise